Loading…
Endovascular Brachytherapy Using Liquid Beta-Emitting Rhenium-188 for the Treatment of Long-Segment Femoropopliteal In-Stent Stenosis
Purpose To evaluate the efficacy and safety of endovascular brachytherapy with liquid beta-emitting rhenium-188 (Re-188) in patients with long-segment in-stent stenosis in the femoropopliteal segment. Methods From July 2009 to April 2011, 90 consecutive patients (59 men; mean age 68.3±10.3 years, ra...
Saved in:
Published in: | Journal of endovascular therapy 2012-08, Vol.19 (4), p.467-475 |
---|---|
Main Authors: | , , , , , , , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | Purpose
To evaluate the efficacy and safety of endovascular brachytherapy with liquid
beta-emitting rhenium-188 (Re-188) in patients with long-segment in-stent
stenosis in the femoropopliteal segment.
Methods
From July 2009 to April 2011, 90 consecutive patients (59 men; mean age
68.3±10.3 years, range 43–86) with symptomatic in-stent
stenosis/occlusion (24.6-cm mean lesion length) of the femoropopliteal
segment underwent angioplasty and subsequent endovascular brachytherapy. The
liquid beta-emitting Re-188 was applied to the target lesion within an
angioplasty balloon using a dose of 13 Gy at a depth of 2 mm into the vessel
wall. Clinical and angiographic follow-up data were collected up to 2 years.
The main study endpoints were the 6- and 12-month primary patency rates
defined as |
---|---|
ISSN: | 1526-6028 1545-1550 |
DOI: | 10.1583/12-3832R.1 |